Ma, D.; Wang, Y.; Huang, N.; Li, W.; Chen, H.; Yang, Y.; Zhu, R.
COVID-19-Associated Disease Course Is Shortened in Moderate-to-Severe Atopic Dermatitis Patients Receiving Dupilumab Treatment: A Retrospective Cross-Sectional Study. J. Clin. Med. 2023, 12, 3415.
https://doi.org/10.3390/jcm12103415
AMA Style
Ma D, Wang Y, Huang N, Li W, Chen H, Yang Y, Zhu R.
COVID-19-Associated Disease Course Is Shortened in Moderate-to-Severe Atopic Dermatitis Patients Receiving Dupilumab Treatment: A Retrospective Cross-Sectional Study. Journal of Clinical Medicine. 2023; 12(10):3415.
https://doi.org/10.3390/jcm12103415
Chicago/Turabian Style
Ma, Dongxia, Yin Wang, Nan Huang, Wenjing Li, Hao Chen, Yaqi Yang, and Rongfei Zhu.
2023. "COVID-19-Associated Disease Course Is Shortened in Moderate-to-Severe Atopic Dermatitis Patients Receiving Dupilumab Treatment: A Retrospective Cross-Sectional Study" Journal of Clinical Medicine 12, no. 10: 3415.
https://doi.org/10.3390/jcm12103415
APA Style
Ma, D., Wang, Y., Huang, N., Li, W., Chen, H., Yang, Y., & Zhu, R.
(2023). COVID-19-Associated Disease Course Is Shortened in Moderate-to-Severe Atopic Dermatitis Patients Receiving Dupilumab Treatment: A Retrospective Cross-Sectional Study. Journal of Clinical Medicine, 12(10), 3415.
https://doi.org/10.3390/jcm12103415
